Assessment
Questionnaire
Have a symptom?
See what questions
a doctor would ask.
See what questions
a doctor would ask.
CoTherix Inc. has had it's new drug Ventavis approved by the FDA for use as an inhalant treatment for pulmonary arterial hypertension in patients with heart failure symptoms. Roughly 50,000 US people are believed to have the condition but only 15,000 have been diagnosed and are being treated.
Source: summary of medical news story as reported by Forbes
About: FDA approves new pulmonary arterial hypertension drug
Date: 29 December 2004
Source: Forbes
URL:
http:/ This summary article refers to the following medical categories:
Tools & Services:
Medical Articles:
Related Medical Topics
More News Topics
» Next page: FDA approves Prozac use by children
Medical Tools & Articles:
Forums & Message Boards
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2011 Health Grades Inc. All rights reserved. Last Update: 6 May, 2013 (23:56)
